文献速递儿童青少年精神物质与行为成瘾

产前大麻暴露与儿童结局的关联:ABCD研究结果

Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study.
PubMed 文献 · JAMA Psychiatry · 2021-01-01

该横断面研究基于ABCD研究基线数据,纳入11 489名9-11岁儿童,评估产前大麻暴露与儿童精神病理、认知、睡眠、出生体重、胎龄、BMI及脑结构的关联。结果显示,产前大麻暴露与儿童精神病理特征、睡眠问题、BMI较高及认知和灰质体积较低相关;在纳入潜在混杂因素后,知道怀孕后暴露仍与精神病理特征相关,而仅孕前暴露则无显著差异。研究建议孕期应避免使用大麻。

要点

  • 产前大麻暴露与儿童期精神病理特征、睡眠问题及较低认知相关。
  • 知道怀孕后继续暴露与较低出生体重及脑白质体积相关。
  • 控制混杂因素后,仅孕前暴露与无暴露在结局上无差异。

核心结论

  • 产前大麻暴露及其相关因素与儿童中期精神病理风险增加相关。
  • 孕期使用大麻应被劝阻。

研究设计与样本

  • 横断面研究,数据来自正在进行的纵向ABCD研究基线 session。
  • 分析样本为11 489名具有非缺失产前大麻暴露数据的儿童(5997名男孩[52.2%];平均[SD]年龄9.9[0.6]岁)。

主要发现

  • 655名(5.7%)儿童产前暴露于大麻。
  • 仅孕前暴露(413名[3.6%])和知道怀孕后暴露(242名[2.1%])均与更高精神病理特征(PLEs及内化、外化、注意、思维、社交问题)、睡眠问题、BMI较高、认知较低及灰质体积较低相关(所有|β|>0.02;所有FDR校正P<.03)。
  • 仅知道怀孕后暴露还与较低出生体重、总颅内体积及白质体积相关(所有|β|>0.02;所有FDR校正P<.04)。
  • 纳入潜在混杂协变量后,知道怀孕后暴露仍与更高PLEs及外化、注意、思维、社交问题相关(所有β>0.02;FDR校正P<.02)。
  • 考虑潜在混杂变量后,仅孕前暴露在任何结局上与无暴露无差异(所有|β|<0.02;FDR校正P>.70)。

临床怎么用

  • 临床应建议孕妇避免使用大麻,尤其知道怀孕后应停止使用。
  • 对产前大麻暴露儿童应关注精神病理症状、睡眠及认知发展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: In light of increasing cannabis use among pregnant women, the US Surgeon General recently issued an advisory against the use of marijuana during pregnancy. OBJECTIVE: To evaluate whether cannabis use during pregnancy is associated with adverse outcomes among offspring. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, data were obtained from the baseline session of the ongoing longitudinal Adolescent Brain and Cognitive Development Study, which recruited 11 875 children aged 9 to 11 years, as well as a parent or caregiver, from 22 sites across the United States between June 1, 2016, and October 15, 2018. EXPOSURE: Prenatal cannabis exposure prior to and after maternal knowledge of pregnancy. MAIN OUTCOMES AND MEASURES: Symptoms of psychopathology in children (ie, psychotic-like experiences [PLEs] and internalizing, externalizing, attention, thought, and social problems), cognition, sleep, birth weight, gestational age at birth, body mass index, and brain structure (ie, total intracranial volume, white matter volume, and gray matter volume). Covariates included familial (eg, income and familial psychopathology), pregnancy (eg, prenatal exposure to alcohol and tobacco), and child (eg, substance use) variables. RESULTS: Among 11 489 children (5997 boys [52.2%]; mean [SD] age, 9.9 [0.6] years) with nonmissing prenatal cannabis exposure data, 655 (5.7%) were exposed to cannabis prenatally. Relative to no exposure, cannabis exposure only before (413 [3.6%]) and after (242 [2.1%]) maternal knowledge of pregnancy were associated with greater offspring psychopathology characteristics (ie, PLEs and internalizing, externalizing, attention, thought and, social problems), sleep problems, and body mass index, as well as lower cognition and gray matter volume (all |β| > 0.02; all false discovery rate [FDR]-corrected P < .03). Only exposure after knowledge of pregnancy was associated with lower birth weight as well as total intracranial volume and white matter volumes relative to no exposure and exposure only before knowledge (all |β| > 0.02; all FDR-corrected P < .04). When including potentially confounding covariates, exposure after maternal knowledge of pregnancy remained associated with greater PLEs and externalizing, attention, thought, and social problems (all β > 0.02; FDR-corrected P < .02). Exposure only prior to maternal knowledge of pregnancy did not differ from no exposure on any outcomes when considering potentially confounding variables (all |β| < 0.02; FDR-corrected P > .70). CONCLUSIONS AND RELEVANCE: This study suggests that prenatal cannabis exposure and its correlated factors are associated with greater risk for psychopathology during middle childhood. Cannabis use during pregnancy should be discouraged.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Paul SE, Hatoum AS, Fine JD, et al. Associations Between Prenatal Cannabis Exposure and Childhood Outcomes: Results From the ABCD Study. JAMA Psychiatry. 2021. PMID: 32965490. doi:10.1001/jamapsychiatry.2020.2902

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。